Urgent changes needed for authorisation of phase I trials.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D017321:Clinical Trials, Phase I as Topic / Q000009:adverse effects / Q000331:legislation & jurisprudence / Q000379:methods*; D006801:Humans; D013045:Species Specificity; D006113:United Kingdom
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C509303:TGN-1412